AstraZeneca stops trial of lung cancer drug
February 28th, 2008
AstraZeneca, the pharmaceutical group, has stopped a trial of an experimental medicine to treat lung cancer amid safety concerns.
Recentin, a drug that aims to starve tumours by cutting off their blood supply, was being tested for non-small cell lung cancer – the most common form of lung cancer – in a trial in Canada.